CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2024
CANBRIDGE-B: VOLUNTARY ANNOUNCEMENT UPDATE ON THE GROUP'S BUSINESS OPERATIONS IN THE UNITED STATES
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024
CANBRIDGE-B: VOLUNTARY ANNOUNCEMENT - ANNOUNCEMENT OF THE GRANT OF PRIORITY REVIEW STATUS OFCAN103 FOR THE TREATMENT OF GAUCHER DISEASE (GD)
CANBRIDGE-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
CANBRIDGE-B: APPOINTMENT AND RESIGNATION OF NON-EXECUTIVE DIRECTORCHANGE IN COMPOSITION OF BOARD COMMITTEE
CANBRIDGE-B: RESIGNATION OF CHIEF FINANCIAL OFFICER
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2024
CANBRIDGE-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
CANBRIDGE-B: RESIGNATION OF NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF BOARD COMMITTEE
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2024
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2024
CANBRIDGE-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 27, 2024
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024
CANBRIDGE-B: CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
CANBRIDGE-B: 2023 Environmental, Social and Governance Report
CANBRIDGE-B: INSIDE INFORMATION RESULTS OF CAN008 PHASE II CLINICAL TRIAL FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME
CANBRIDGE-B: CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG
CANBRIDGE-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024
No Data
No Data